Cerus (CERS) EBT Growth (1y) (2011 - 2026)
Cerus (CERS) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 5.78% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -27.02% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 74.66% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 54.33% |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 79.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.63% |
| Dec 31, 2025 | 619.22% |
| Sep 30, 2025 | 102.27% |
| Jun 30, 2025 | 3.29% |
| Mar 31, 2025 | 20.51% |
| Dec 31, 2024 | -108.15% |
| Sep 30, 2024 | 60.35% |
| Jun 30, 2024 | 55.94% |
| Mar 31, 2024 | 38.22% |
| Dec 31, 2023 | 361.84% |
| Sep 30, 2023 | 14.74% |
| Jun 30, 2023 | -59.11% |
| Mar 31, 2023 | -27.49% |
| Dec 31, 2022 | -130.89% |
| Sep 30, 2022 | 31.62% |
| Jun 30, 2022 | 45.58% |
| Mar 31, 2022 | 29.67% |
| Dec 31, 2021 | 419.88% |
| Sep 30, 2021 | 12.13% |
| Jun 30, 2021 | -3.24% |